# Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients

> **NCT02949674** · PHASE3 · COMPLETED · sponsor: **Instituto Mexicano del Seguro Social** · enrollment: 93 (actual)

## Conditions studied

- Ankle Fractures
- Pain, Postoperative
- Local Infiltration

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Bupivacaine

## Key facts

- **NCT ID:** NCT02949674
- **Lead sponsor:** Instituto Mexicano del Seguro Social
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2016-10
- **Final completion:** 2017-04
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02949674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02949674, "Ropivacaine Versus Bupivacaine as Preemptive Analgesia in Surgical Site in Ankle Fracture Patients". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02949674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*